- Home
- CUE vs ASYS Comparison
CUE vs ASYS Comparison
Compare CUE & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- ASYS
- Stock Information
- Founded
- CUE 2014
- ASYS 1981
- Country
- CUE United States
- ASYS United States
- Employees
- CUE N/A
- ASYS N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- ASYS Industrial Machinery/Components
- Sector
- CUE Health Care
- ASYS Technology
- Exchange
- CUE Nasdaq
- ASYS Nasdaq
- Market Cap
- CUE 48.0M
- ASYS 49.8M
- IPO Year
- CUE 2018
- ASYS N/A
- Fundamental
- Price
- CUE $0.70
- ASYS $4.15
- Analyst Decision
- CUE Strong Buy
- ASYS
- Analyst Count
- CUE 3
- ASYS 0
- Target Price
- CUE $3.00
- ASYS N/A
- AVG Volume (30 Days)
- CUE 220.4K
- ASYS 40.4K
- Earning Date
- CUE 08-13-2025
- ASYS 08-06-2025
- Dividend Yield
- CUE N/A
- ASYS N/A
- EPS Growth
- CUE N/A
- ASYS N/A
- EPS
- CUE N/A
- ASYS N/A
- Revenue
- CUE $7,991,000.00
- ASYS $90,826,000.00
- Revenue This Year
- CUE N/A
- ASYS N/A
- Revenue Next Year
- CUE $23.84
- ASYS $28.60
- P/E Ratio
- CUE N/A
- ASYS N/A
- Revenue Growth
- CUE 13.83
- ASYS N/A
- 52 Week Low
- CUE $0.45
- ASYS $3.20
- 52 Week High
- CUE $1.99
- ASYS $6.96
- Technical
- Relative Strength Index (RSI)
- CUE 55.84
- ASYS 55.03
- Support Level
- CUE $0.54
- ASYS $4.04
- Resistance Level
- CUE $0.66
- ASYS $4.37
- Average True Range (ATR)
- CUE 0.06
- ASYS 0.18
- MACD
- CUE 0.01
- ASYS 0.01
- Stochastic Oscillator
- CUE 81.98
- ASYS 53.19
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.